December 15th, 2015

Acquisitions & Postive Drug Data Boost SBIO ETF Again

By ALPS Funds Last week, the ALPS Medical Breakthroughs ETF (SBIO) posted gains of around 1% and outperformed broader equity markets as well as large-cap biotech indices. Valuations for SBIO’s small-to-mid cap biotech holdings were buoyed by positive M&A (merger & acquisition) sentiment...
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.